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Abstract Loss-of-function mutations of the KAL1 gene are a
known cause of Kallmann syndrome, a disorder characterized
by the coexistence of hypogonadotropic hypogonadism and
anosmia/hiposmia. On the other hand, neither complete nor
partial duplications of KAL1 have been reported in the litera-
ture; thus, clinical symptoms associated with such alterations
remain unknown. Ectrodactyly is a clinically and genetically
heterogeneous abnormality presenting with hypoplasia of the
central rays of the extremity, which, in around 68 % of cases,
has unknown underlying molecular defect. In this paper, we
report on a sporadic male patient manifesting hyperosmia and
ectrodactyly accompanied by additional symptoms involving
mild intellectual disability, unilateral hearing loss, genital
anomalies, stocky build, and facial dysmorphism. Using a
combination of high-resolution array comparative genomic
hybridization (array CGH) and breakpoint analysis, we de-
tected a hemizygous tandem duplication of 110,967 bp on
Xp22.31, encompassing the promoter region and the first two
exons of KAL1. In order to confirm pathogenicity of the
duplication, we tested the level of KAL1 transcript in blood
lymphocytes, showing 79 times higher expression in the pro-
band compared to controls. We, therefore, hypothesize that
olfactory hypersensitivity in our proband directly results from
KAL1 overproduction. Additionally, a literature review
allowed us to conclude that KAL1 protein at high levels may
interfere with FGFR1 signaling activity, most probably indi-
rectly giving rise to ectrodactyly, intellectual disability, and
genital anomalies. Noteworthy, those symptoms overlap with
Hartsfield syndrome caused by FGFR1 loss-of-function mu-
tations. To conclude, our paper highlights the role of KAL1 in
embryogenesis and provides data on the contribution ofKAL1
overexpression to human pathology.
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Introduction
Congenital limb anomalies categorized as split hand/foot mal-
formation (SHFM; OMIM 183600) are phenotypically het-
erogeneous disorders; however, the common characteristic
feature shared by all types of SHFM involves the absence or
hypoplasia of the central ray(s) of the autopod. In its most
severe form, the aplasia of both central and preaxial rays of the
hands and/or feet leads to monodactyly. Clinical heterogeneity
of SHFM (also referred to as ectrodactyly) results mostly from
variable expressivity of the feature, which often manifests
inconstantly in closely related patients or even in different
limbs of a single individual (Basel et al. 2006). Ectrodactyly
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occurs either as an isolated trait or part of a multiple congenital
anomaly syndrome. Themalformation is caused by a failure in
the development or maintenance of the median apical ecto-
dermal ridge (AER), a group of cells located in the most distal
portion of the developing limb bud (Duijf et al. 2003). To date,
seven loci associated with non-syndromic SHFM have been
described. These include: SHFM1 (OMIM 183600, caused by
various rearrangements in the 7q21.3 locus or point mutations
in DLX5), SHFM2 (OMIM 313350, located in Xq26),
SHFM3 (OMIM 246500, resulting from tandem duplications
of the 10q24-q25 locus), SHFM4 (OMIM 605289, caused by
heterozygous mutations in TP63), SHFM5 (OMIM 606708,
linked to deletions in the 2q31 locus), SHFM6 (OMIM 22530,
associated with homozygous mutations in WNT10B), as well
as the most common form, i.e., SHFM/SHFLD3; MIM
612576 (caused by 17p13.3 duplication encompassing
BHLHA9) (Scherer et al. 1994; Faiyaz-Ul-Haque et al. 2005;
Gurrieri et al. 1996; van Bokhoven et al. 2001; Klopocki et al.
2012; Goodman et al. 2002; Sowińska-Seidler et al. 2014).
Despite recent progress and dissemination of molecular diag-
nostic and research techniques, the genetic cause of the ma-
jority of SHFM cases remains unresolved (Klopocki and
Mundlos 2011; Klopocki et al. 2012; Biegański et al. 2012;
Tayebi et al. 2014).
Structural copy number variations (CNVs) are a known
cause of human limb malformations, and the number of stud-
ies associating various CNVs with developmental limb disor-
ders is constantly growing (Klopocki and Mundlos 2011;
Klopocki et al. 2012; Jamsheer et al. 2013). The contribution
of submicroscopic genomic rearrangements to the pathogen-
esis of human malformations can occur via several mecha-
nisms. The most common involves alteration of the copy
number of a dosage-sensitive gene or gene cluster. In this
setting, deletions or duplications simply lead to the
haploinsufficiency or overexpression of a gene, respectively.
In some cases, deletions and duplications of the same dosage-
susceptible gene give rise to different clinical conditions, as
previously shown, for example, for SOX9, MECP2, or
PMP22 (Benko et al. 2009; Kurth et al. 2009; Meins et al.
2005; Van Esch et al. 2005; Patel et al. 1992; Valentijn et al.
1995; Chance et al. 1993). Alternatively, CNVs can also cause
position effects and disturb gene expression by changing the
number or location of regulatory elements or by altering the
entire regulatory landscape of a target gene or gene cluster
(Klopocki and Mundlos 2011).
The KAL1 gene is involved in embryonic development of
the kidney and human central nervous system, including the
spinal cord, olfactory bulbs, olfactory nerves, and retina
(Duke et al. 1995). While KAL1 loss-of-function alterations
(i.e., deletions and point mutations) are a known cause of X-
linked Kallmann syndrome (KS), which is characterized by
the association of hypogonadotropic hypogonadism (HH) and
anosmia/hiposmia, complete or partial duplications of this
gene have not been reported in the literature. Thus, clinical
symptoms associated with KAL1 duplications and/or in-
creased gene expression remain unknown.
In this paper, we report on a sporadic male patient present-
ing with SHFM and hyperosmia accompanied with additional
congenital abnormalities, most likely resulting from a partial
duplication of KAL1 and significant overexpression of this
gene. Our paper provides further evidence on the contribution
of CNVs to congenital malformations in humans and high-
lights the role of KAL1 in embryonic development.
Methods
All patients agreed to participate in this study and informed
consent was obtained from all subjects or their legal guardians
prior to genetic testing. Ethics approval was granted by the
Institutional Review Board of the Poznan University of Med-
ical Sciences.
Array comparative genomic hybridization (array CGH)
Genomic DNA was extracted from peripheral blood leuko-
cytes according to the salting-out method. Array comparative
genomic hybridization (array CGH) was carried out with the
use of the 1.4M NimbleGen oligonucleotide CGH array
(Roche NimbleGen), according to standard protocols provid-
ed by the manufacturer. Analysis was done with Deva soft-
ware (Roche NimbleGen). The analysis settings were as fol-
lows: aberration algorithm: ADM-2; threshold: 6.0; window
size: 0.2 Mb; filter: five probes, log2 ratio=0.29. The genomic
profile was visualized by the SignalMap Software
(SignalMap, NimbleGen Systems, Inc.).
Quantitative real-time polymerase chain reaction (qPCR)
In order to confirm array CGH results and narrow down the
genomic coordinates of the rearrangement, we performed a
quantitative real-time polymerase chain reaction (qPCR)
using a ViiA™ 7 Real-Time thermal cycler (Applied
Biosystems). The qPCR assay was designed to determine
the number of copies in the vicinity of both 5′ and 3′ ends of
the duplicated Xp22.31 segment. The test was carried out with
a set of six and three primer pairs, respectively. The qPCR
reaction was performed in a total volume of 12 μl in each well
containing 6 μl of SYBR Green PCR Master Mix (Applied
Biosystems), 5 μl of genomic DNA (2 ng/μl), and 0.5 μl of
forward and reverse primer each (10 μmol/l). The PCR con-
ditions were as follows: initial denaturation step at 95 °C
followed by 40 cycles of denaturation at 95 °C for 15 s and
annealing with elongation at 60 °C for 1 min). All reactions
were run in triplicate. Target sequences were normalized to
albumin (ALB) and, to further assure reliability of the assay,
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sex determination was performed in reference to factor VIII
(F8) located on the X chromosome. The gene copy number
was determined with the comparative DDCt method using
normal healthy control DNA as a calibrator.
Breakpoint sequencing
The exact breakpoints of the rearrangement were determined
with the use of PCR with primers designed to amplify the
DNA fragment spanning the 3′ and 5′ ends of the duplication.
PCRwas performed in a total volume of 10 μl containing 1 μl
of Buffer I (PCR Expand Long Template PCR System v.24;
Roche), 0.6 μl of primers (10 μmol/l each), 0.35 μl of dNTPs
mix (10 mM), 1 μl of genomic DNA (150 ng/μl), 0.15 μl of
DNA polymerase (PCR Expand Long Template PCR System
v.24; Roche), and 6.4 μl of PCR-grade water. The PCR
conditions were as follows: initial denaturation step at 94 °C
for 2 min followed by 10 cycles of denaturation at 94 °C for
10 s, annealing at 60 °C for 30 s, and elongation at 68 °C for
2 min), another 25 cycles of denaturation at 94 °C for 15 s,
annealing at 60 °C for 30 s, and elongation at 68 °C for 140 s,
and final elongation at 68 °C for 7 min. The PCR product was
then sequenced using dye-terminator chemistry (kit v.3, ABI
3130xl) and run on an automated sequencer, Applied
Biosystems PRISM 3700 DNA Analyzer.
KAL1 relative expression
In order to measure the expression level of the KAL1 gene in
our index case, we performed the relative expression analysis
for KAL1 in blood samples of the proband and seven controls.
Total RNAwas extracted from peripheral blood mononuclear
cells (PBMCs) of the proband and control samples according
to the method of Chomczyński and Sacchi (1987). PBMCs
were separated from whole blood in a density gradient of
Ficoll and sodium diatrizoate (Histopaque®-1077; Sigma).
RNA samples were reversely transcribed into cDNA using a
mix of oligo-dT and random primers (QuantiTect Reverse
Transcription Kit; Qiagen), according to standard protocols
provided by the manufacturer.
Quantifications of target and reference genes in cDNA
samples were carried out by fluorometric real-time PCR using
a LightCycler 480 instrument (Roche Diagnostic GmbH,
Mannheim, Germany), a real-time PCR kit (LightCycler®
480 Probes Master), and Universal Probe Library (UPL)
probes. For each individual cDNA sample, Cp values were
determined in triplicate. The assay was performed using a 96-
well plate setup with a final volume of 10 μl/well, consisting
of 0.5 μM of each gene-specific primer, 0.1 μM of the
appropriate UPL probe, 5 μl of LightCycler® 480 Probes
Master mix, 1μl of the cDNA template, and PCR-grade water.
The PCR protocol consisted of an initial denaturation at 95 °C
for 5 min, followed by 45 cycles of amplification consisting of
denaturation at 95 °C for 10 s, annealing at 55 °C for 30 s, and
elongation at 72 °C for 10 s.
Relative expression values of KAL1 were obtained using
the LightCycler480 Software by determining the ratio be-
tween the target and two reference transcripts (ACTB, HPRT).
Error bars represent the target/reference error calculated by the
LightCycler480 Software in a single experiment performed in
triplicate. Relative expression values were normalized to the
mean of the controls (K1–K7).
Fusion transcript relative expression
The relative expression value of the KAL1 fusion transcript in
the proband was determined using the comparative DDCt
method by intra-sample normalization to the endogenous
control gene PBGD and inter-sample normalization to the
KAL1 wild-type transcript, used here as a calibrator. The
experiment was carried out with the use of a ViiA™ 7 Real-
Time PCR System (Applied Biosystems) and SYBR Green
PCR Master Mix (Applied Biosystems). The qPCR reaction
was performed using a 96-well plate in a total volume of 12 μl
in each well containing 6 μl of SYBRGreen PCRMaster Mix
(Applied Biosystems), 1 μl of cDNA, 0.5 μl of forward and
reverse primer each (10 μmol/l), and 4 μl of PCR-grade water.
The PCR conditions were as follows: initial denaturation step
at 95 °C followed by 40 cycles of denaturation at 95 °C for
15 s and annealing with elongation at 64 °C for 1 min). All
reactions were run in triplicate. Primers for the target sequence
were designed to specifically amplify the fusion transcript and
not the wild-type form.
Results
Clinical report
The proband, a 12-year-old boy of Polish ethnicity, was born
by spontaneous delivery after an uneventful pregnancy
(G1P1) at 41 weeks and 3 days of gestation to a non-
consanguineous and healthy 21-year-old mother and a 24-
year-old father. At birth, his weight was 2,980 g (3rd−10th
percentile), length 51 cm (50th percentile), head circumfer-
ence 32 cm (below the 3rd percentile), and his Apgar score
was 5, 7, 9, and 10 at 1, 3, 5, and 10 min, respectively.
Physical examination after birth revealed bilateral malforma-
tion of the feet composed of hypoplasia and syndactyly of the
postaxial toes, which could have been categorized as
ectrodactyly. Additionally, the left hand showed a supernu-
merary digit, which was fused with the index finger.
Transfontanellar ultrasound performed after birth and at day
26 revealed bilateral intraventricular hemorrhage (IVH) of the
first degree, whereas abdominal ultrasound was normal. X-ray
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scan showed fused processus spinosus of L4 and L5. Hearing
tests done at 9 months of age showed profound left-sided
hypoacusis and normal right-sided hearing. Ophthalmologic
examination was unremarkable. At the age of 3 years, the
patient was operated on the hydrocele of the left testis, as well
as cryptorchidism of the right testis. According to anamnesis,
motor development was normal, with independent sitting and
walking achieved on time (6 and 12 months, respectively).
Expressive speech was delayed, with the first several words at
4 years of age. Due to congenital defects and delayed speech
at that time, the proband was referred for a conventional
chromosomal analysis (performed on peripheral blood lym-
phocytes with a resolution of 550 bands per haploid genome),
which showed normal male karyotype (46, XY). Psycholog-
ical assessment performed at the age of 8 years according to
the WISC-R test showed 59 points in the verbal scale, 82
points in the non-verbal scale, and 67 points in the full scale.
In addition, at the same time, the patient was diagnosed with
attention deficit hyperactivity disorder (ADHD). Throughout
the childhood, the boy manifested increased sensitivity to
smell. Upon repeated brain magnetic resonance imaging
(MRI) scans, a cyst of septum lucidum 5×26 mm in size
was noted. At the age of 11 years and 6 months, the body
measurements were as follows: height 141 cm (25th percen-
tile), weight 50.0 kg (75th−90th percentile), and body mass
index (BMI) 25.25 (90th−97th percentile). Bone age assess-
ment based on left carpal X-ray was relevant to the metrical
age.
The boy was referred to our genetic clinic for diagnosis and
first investigated at the age of 12 years. Upon examination, he
presented with stocky build, obesity, steatomastia, small penis,
and craniofacial dysmorphic features comprising round face,
full cheeks, hypotelorism, up-slanted palpebral fissures, and
hypoplastic alae nasi (no consent for publication of the full-
face photo). His upper limb malformation was bilateral and
comprised hypoplastic middle and distal phalanges of fingers
2–5 (as shown in Fig. 1a, b). Lower limb malformation could
be categorized as ectrodactyly and was composed of hypopla-
sia and syndactyly of toes 2–5, which had rudimentary or
absent middle and distal phalanges. In addition, both feet
showed severe hypoplasia of one digital ray (Fig. 1c, d).
Due to the reported increased sensitivity to smell, we decided
to perform objective olfactory analyses. While quantitative
olfactory examination was symmetrically normal, the regis-
tration of olfactory evoked potentials (OEPs) showed consid-
erable increase of the amplitudes symmetrical on both sides.
Upon stimulation with peppermint oil and anise oil, the OEP
amplitudes were elevated 20 times for nerve I (N1=320 ms)
and 15 times for nerve V (N5=320 ms), showing extreme
olfactory hypersensitivity in comparison with the reference
values. Endocrinological tests done at 12 years of age showed
normal results of TSH, fT3, fT4, FSH, LH PRL, and ACTH.
Night release of growth hormone (GH) was unremarkable.
Luteinizing hormone-releasing hormone (LH-RH) stimula-
tion test showed normal levels of FSH, LH, and testosterone.
The family tree of the proband is presented in Fig. 1e.
Array CGH
Array CGH performed in the index and subsequently his
mother revealed an interstitial microduplication in the
Xp22.31 locus, with a minimal size of 108,316 bp (genomic
coordinates 8596840–8705155 according to HG19; shown in
Fig. 2a). The duplication encompassed exclusively the pro-
moter region and the first two exons and introns of the KAL1
gene (for a schematic representation, see Fig. 2b) and was
inherited from the clinically unaffected mother.
Fig. 1 Limb phenotype of the proband and his family tree: a, b clinical
and radiological presentation of the malformation observed in the left
hand, c, d clinical and radiological picture of the ectrodactyly noted in the
proband’s feet, e pedigree tree showing that the index case is the only
affected member of the family. The mother of the proband and maternal
sister are the healthy carriers of the duplication. Legend for other genetic
conditions occurring within this family: 1 gastroschisis, 2 lethal osteo-
genesis imperfecta, 3 Down syndrome
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qPCR and breakpoint analysis
First, the qPCR assay was carried out with a set of five primer
pairs in the proband and his mother, in whom it confirmed the
array CGH results. Next, other rounds of qPCR done in the
proband allowed to narrow down the duplication region,
thereby enabling us to design primers for breakpoint sequenc-
ing. The exact breakpoints were established by means of PCR
with primers involving centromeric and telomeric ends of the
microduplication, followed by Sanger sequencing of the PCR
product. The exact size of the duplication was 110,967 bp,
with genomic coordinates according to HG19 located between
8594879 and 8705846. The breakpoint spanning sequences
are shown in Fig. 2c. Finally, we performed segregation
studies in all available family members, i.e., unaffected ma-
ternal sister and her healthy son. Using qPCR (five primer
pairs), we demonstrated that the maternal sister was a hetero-
zygous carrier of the duplication, whereas her son had a single
copy of the tested region.
Fusion transcript analysis
In silico prediction suggested the possibility of the production
of two distinct KAL1 transcripts in our proband. In addition to
the wild-type transcript, a fusion transcript containing an
insert of 405 nucleotides derived from the duplicated KAL1
segment could have been expressed. cDNA sequencing of
KAL1 showed the expression of both forms in our proband.
The fusion transcript is predicted to give rise to a fusion
protein containing 135 additional amino acids at the 5′ end
(for the sequence of the putative fusion KAL1 protein, see
Fig. 2d).
KAL1 relative expression
The analysis of KAL1 relative expression performed in blood
samples of the proband and seven controls revealed 79 times
higher expression level of the KAL1 gene in the proband
compared to the mean value of the controls (Fig. 3). The
Fig. 2 a Ideogram of the array comparative genomic hybridization
(CGH) results; the red box indicates the duplicated region encompassing
the 5′ fragment of the KAL1 gene. b Schematic representation of the
microduplication in the Xp22.31 locus. c Breakpoint sequencing result: a
110,967-kb duplication, with genomic coordinates located between
8594879 and 8705846 according to HG19. d Amino acid sequence of
the KAL1 fusion protein; the red box indicates the duplication including
the translated fragment of 5′-UTR (marked in red color) and the first two
coding exons (highlighted by black and blue colors, respectively). The
green color indicates amino acid residues encoded by the exon–exon
junctions. (Color figure online)
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relative expression of the fusion KAL1 transcript in our pro-
band referred to the total pool of KAL1 mRNA was 0.3 %,
suggesting highly preferential expression of the wild-type
KAL1 form.
Discussion
In this paper, we report on a sporadic male patient presenting
with SHFM and profound hyperosmia, accompanied with
additional symptoms involving mild intellectual disability,
unilateral hearing loss, cryptorchidism, small penis, stocky
build, and facial dysmorphism. Since the patient did not show
any known recognizable genetic syndrome, we performed
high-resolution whole-genome array CGH in order to test
for possible imbalanced submicroscopic genomic rearrange-
ment. In the proband, we detected a hemizygous interstitial
duplication of 110,967 kb in the Xp22.31 locus, which
encompassed the promoter region and the first two exons of
the KAL1 gene. The structural variation showed tandem ori-
entation and was subsequently identified in heterozygosity in
the healthy mother of the index case.
The KAL1 gene is expressed during human embryonic
development in the spinal cord, kidney, olfactory bulb, and
retina (Duke et al. 1995). Its gene product, anosmin-1, repre-
sents a secreted extracellular heparin-binding cell adhesion
glycoprotein that controls axonal pathfinding and develop-
ment of olfactory nerves, as well as migration of
gonadotropin-releasing hormone (GnRH) producing neurons
to the septohypothalamic area (Cariboni et al. 2004). Loss-of-
function mutations of KAL1, such as point mutations or dele-
tions of variable size, have been associated with an X-linked
form of KS, accounting for 10–12 % of KS cases. The disease
is characterized by HH due to GnRH deficiency and anosmia
or hiposmia resulting from olfactory bulb dysgenesis. In ad-
dition, other anomalies such as sensorineural deafness, renal
aplasia, cleft lip/palate, and skeletal defects are known to
occur (Dodé et al. 2003). To our knowledge, neither partial
nor complete microduplications of KAL1 have been described
in the literature. Consequently, the phenotype associated with
such CNVs remains unknown. Therefore, since our proband
carried a partial duplication of the 5′ end of theKAL1 gene, we
tested the expression level of this gene in order to confirm
pathogenicity of the CNV. Based on blood lymphocyte stud-
ies, our proband showed around 80 times higher expression of
the KAL1 gene compared to healthy controls. Unlike KS
patients usually affected by hiposmia or anosmia, our proband
presented with hyperosmia, which very likely resulted directly
from the overproduction of KAL1 during embryonic develop-
ment. The mechanism by whichKAL1 is overexpressed in our
proband due to the duplication of its 5′ end remains obscure.
One possible explanation is that the duplication encompasses
yet unidentified KAL1 enhancer(s), which, by acting in cis in
two copies, drive significantly stronger expression of the
target gene. Another explanation assumes that, due to the
duplication of the promoter region, a putative KAL1 repressor
becomes unable to occupy a newly emerging locus, which, in
turns, leads to the repressor insufficiency and increase in target
gene expression.
The product of KAL1, anosmin-1, is known to directly
stimulate tyrosine kinase activity of the fibroblast growth
factor receptor 1 (FGFR1), an important signaling molecule
involved in a wide range of developmental processes. Loss-of-
function mutations of the FGFR1 gene are another cause of
KS identified in approximately 10 % of cases (Dodé et al.
2003). The FGFR1-dependent form of KS is inherited in an
autosomal dominant manner and frequently presents with
limb anomalies such as fusion of the fourth and fifth metacar-
pals, oligodactyly, and clinodactyly (Jarząbek et al. 2012;
Dodé et al. 2003). The role of Fgfr1 in embryogenesis was
established in mouse developmental studies, in which condi-
tionalFgfr1 knockout organismsmanifested cerebral and limb
anomalies (Tole et al. 2006; Li et al. 2005; Verheyden et al.
2005; Yu and Ornitz 2008). Decreased Fgfr1 expression or its
complete biallelic inactivation in telencephalon prevents the
formation of commissural tracts due to the loss of axonal
midline crossing (Tole et al. 2006). In addition, conditional
Fgfr1 knockout mice show aplasia of digits in the central and
anterior rays of the autopods, as well as osseous syndactyly of
digits III and IV (Li et al. 2005; Verheyden et al. 2005; Yu and
Ornitz 2008). These observations point to the importance of
Fgfr1 in limb bud and nervous system formation, and explain
Fig. 3 Bar graph showing the relative expression ofKAL1 in the proband
in reference to the mean value of seven healthy controls. The expression
of the KAL1 transcript in the proband is 79 times higher compared to the
controls
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the link between insufficient FGFR1 activity and several
human congenital malformations, such as agenesis of corpus
callosum, hypoplasia of olfactory bulbs, holoprosencephaly,
ectrodactyly, or other limb defects.
It was shown that anosmin-1 stimulates the signaling ac-
tivity of FGFR1 receptor IIIc isoform via direct binding of its
N-terminal region to FGFR1 ectodomains (Hu et al. 2009). On
the contrary, at high levels, anosmin-1 can also exert inhibi-
tory effects on the FGFR1 protein (Hu et al. 2009; Ornitz
2000). Therefore, in light of these findings, the overexpression
of KAL1 might mimic haploinsufficiency of FGFR1 receptor.
Interestingly, FGFR1 loss-of-function mutations have been
shown to give rise not only to KS but also to several other
human genetic conditions, such as isolated HH or Hartsfield
syndrome, a disorder characterized by the co-occurrence of
holoprosencephaly and ectrodactyly, in association with de-
velopmental delay/intellectual disability, agenesis of corpus
callosum, genital anomalies, and variable skeletal
malformations (Simonis et al. 2013). Due to significant over-
lap in the clinical presentation of our proband and Hartsfield
syndrome, as well as common biological pathways involved
in the development of both conditions, we hypothesize that
ectrodactyly, developmental delay, speech delay, intellectual
disability, small penis, cryptorchidism, and facial
dysmorphism observed in our proband result from the indirect
inactivation of FGFR1 due to significant overexpression of
KAL1. Of note, there was no evidence for holoprosencephaly
upon brain MRI in our patient; therefore, he could not have
been diagnosed as having Hartsfield syndrome.
To conclude, in this report, we showed for the first time that
increased KAL1 expression may lead to hyperosmia with
significantly increased amplitudes of olfactory evoked poten-
tials. Additionally, we postulate that the partial overlap be-
tween the phenotype of our patient and Hartsfield syndrome
(including ectrodactyly, intellectual disability, and genital
anomalies) may reflect the common pathogenic mechanism
(i.e., disturbed FGFR1 signaling) underlying both conditions.
Finally, we hypothesize that the phenotype of our proband
represents a novel, probably rare, X-linked recessive congen-
ital malformation syndrome with ectrodactyly as a limb fea-
ture, although further reports are needed in order to confirm
our assumptions.
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